Global Cell therapy Processing Market Research Report 2024

Publication ID:

PB502244689

Publication Date:

February 7, 2024

Pages:

101

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Manufacturers [2]

Machinery [3]

Industry & Manufacturing [4]

Description:

The global Cell therapy Processing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Cell therapy Processing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Cell therapy Processing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Cell therapy Processing in Cardiovascular Disease is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Cell therapy Processing include Anthrogenesis Corp., BioNTech, Cell Ideas, Epic Sciences, Roche, FuGENE, IBC Pharmaceuticals Inc., Bluebird Bio Inc. and Immodulon-Therapeutics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cell therapy Processing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell therapy Processing.
Report Scope
The Cell therapy Processing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cell therapy Processing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell therapy Processing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Anthrogenesis Corp.
BioNTech
Cell Ideas
Epic Sciences
Roche
FuGENE
IBC Pharmaceuticals Inc.
Bluebird Bio Inc.
Immodulon-Therapeutics
Immunomedics Inc.
Juno Therapeutics Inc.
Medlmmune Inc.
NeoStem Oncology
Neurotech USA
Novartis
Persimmune Inc.
Pluristem Therapeutics
BioMed Valley Discoveries Inc.
Regeneron Pharmaceuticals Inc.
UCL Business PLC.
Segment by Type
Products
Services
Software
Segment by Application
Cardiovascular Disease
Bone Repair
Neurological Disorders
Skeletal Muscle RepairImmune Diseases
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell therapy Processing companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell therapy Processing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Products
1.2.3 Services
1.2.4 Software
1.3 Market by Application
1.3.1 Global Cell therapy Processing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cardiovascular Disease
1.3.3 Bone Repair
1.3.4 Neurological Disorders
1.3.5 Skeletal Muscle RepairImmune Diseases
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell therapy Processing Market Perspective (2019-2030)
2.2 Cell therapy Processing Growth Trends by Region
2.2.1 Global Cell therapy Processing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cell therapy Processing Historic Market Size by Region (2019-2024)
2.2.3 Cell therapy Processing Forecasted Market Size by Region (2025-2030)
2.3 Cell therapy Processing Market Dynamics
2.3.1 Cell therapy Processing Industry Trends
2.3.2 Cell therapy Processing Market Drivers
2.3.3 Cell therapy Processing Market Challenges
2.3.4 Cell therapy Processing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell therapy Processing Players by Revenue
3.1.1 Global Top Cell therapy Processing Players by Revenue (2019-2024)
3.1.2 Global Cell therapy Processing Revenue Market Share by Players (2019-2024)
3.2 Global Cell therapy Processing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cell therapy Processing Revenue
3.4 Global Cell therapy Processing Market Concentration Ratio
3.4.1 Global Cell therapy Processing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell therapy Processing Revenue in 2023
3.5 Cell therapy Processing Key Players Head office and Area Served
3.6 Key Players Cell therapy Processing Product Solution and Service
3.7 Date of Enter into Cell therapy Processing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell therapy Processing Breakdown Data by Type
4.1 Global Cell therapy Processing Historic Market Size by Type (2019-2024)
4.2 Global Cell therapy Processing Forecasted Market Size by Type (2025-2030)
5 Cell therapy Processing Breakdown Data by Application
5.1 Global Cell therapy Processing Historic Market Size by Application (2019-2024)
5.2 Global Cell therapy Processing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cell therapy Processing Market Size (2019-2030)
6.2 North America Cell therapy Processing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cell therapy Processing Market Size by Country (2019-2024)
6.4 North America Cell therapy Processing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell therapy Processing Market Size (2019-2030)
7.2 Europe Cell therapy Processing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cell therapy Processing Market Size by Country (2019-2024)
7.4 Europe Cell therapy Processing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell therapy Processing Market Size (2019-2030)
8.2 Asia-Pacific Cell therapy Processing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cell therapy Processing Market Size by Region (2019-2024)
8.4 Asia-Pacific Cell therapy Processing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell therapy Processing Market Size (2019-2030)
9.2 Latin America Cell therapy Processing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cell therapy Processing Market Size by Country (2019-2024)
9.4 Latin America Cell therapy Processing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell therapy Processing Market Size (2019-2030)
10.2 Middle East & Africa Cell therapy Processing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cell therapy Processing Market Size by Country (2019-2024)
10.4 Middle East & Africa Cell therapy Processing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Anthrogenesis Corp.
11.1.1 Anthrogenesis Corp. Company Detail
11.1.2 Anthrogenesis Corp. Business Overview
11.1.3 Anthrogenesis Corp. Cell therapy Processing Introduction
11.1.4 Anthrogenesis Corp. Revenue in Cell therapy Processing Business (2019-2024)
11.1.5 Anthrogenesis Corp. Recent Development
11.2 BioNTech
11.2.1 BioNTech Company Detail
11.2.2 BioNTech Business Overview
11.2.3 BioNTech Cell therapy Processing Introduction
11.2.4 BioNTech Revenue in Cell therapy Processing Business (2019-2024)
11.2.5 BioNTech Recent Development
11.3 Cell Ideas
11.3.1 Cell Ideas Company Detail
11.3.2 Cell Ideas Business Overview
11.3.3 Cell Ideas Cell therapy Processing Introduction
11.3.4 Cell Ideas Revenue in Cell therapy Processing Business (2019-2024)
11.3.5 Cell Ideas Recent Development
11.4 Epic Sciences
11.4.1 Epic Sciences Company Detail
11.4.2 Epic Sciences Business Overview
11.4.3 Epic Sciences Cell therapy Processing Introduction
11.4.4 Epic Sciences Revenue in Cell therapy Processing Business (2019-2024)
11.4.5 Epic Sciences Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche Cell therapy Processing Introduction
11.5.4 Roche Revenue in Cell therapy Processing Business (2019-2024)
11.5.5 Roche Recent Development
11.6 FuGENE
11.6.1 FuGENE Company Detail
11.6.2 FuGENE Business Overview
11.6.3 FuGENE Cell therapy Processing Introduction
11.6.4 FuGENE Revenue in Cell therapy Processing Business (2019-2024)
11.6.5 FuGENE Recent Development
11.7 IBC Pharmaceuticals Inc.
11.7.1 IBC Pharmaceuticals Inc. Company Detail
11.7.2 IBC Pharmaceuticals Inc. Business Overview
11.7.3 IBC Pharmaceuticals Inc. Cell therapy Processing Introduction
11.7.4 IBC Pharmaceuticals Inc. Revenue in Cell therapy Processing Business (2019-2024)
11.7.5 IBC Pharmaceuticals Inc. Recent Development
11.8 Bluebird Bio Inc.
11.8.1 Bluebird Bio Inc. Company Detail
11.8.2 Bluebird Bio Inc. Business Overview
11.8.3 Bluebird Bio Inc. Cell therapy Processing Introduction
11.8.4 Bluebird Bio Inc. Revenue in Cell therapy Processing Business (2019-2024)
11.8.5 Bluebird Bio Inc. Recent Development
11.9 Immodulon-Therapeutics
11.9.1 Immodulon-Therapeutics Company Detail
11.9.2 Immodulon-Therapeutics Business Overview
11.9.3 Immodulon-Therapeutics Cell therapy Processing Introduction
11.9.4 Immodulon-Therapeutics Revenue in Cell therapy Processing Business (2019-2024)
11.9.5 Immodulon-Therapeutics Recent Development
11.10 Immunomedics Inc.
11.10.1 Immunomedics Inc. Company Detail
11.10.2 Immunomedics Inc. Business Overview
11.10.3 Immunomedics Inc. Cell therapy Processing Introduction
11.10.4 Immunomedics Inc. Revenue in Cell therapy Processing Business (2019-2024)
11.10.5 Immunomedics Inc. Recent Development
11.11 Juno Therapeutics Inc.
11.11.1 Juno Therapeutics Inc. Company Detail
11.11.2 Juno Therapeutics Inc. Business Overview
11.11.3 Juno Therapeutics Inc. Cell therapy Processing Introduction
11.11.4 Juno Therapeutics Inc. Revenue in Cell therapy Processing Business (2019-2024)
11.11.5 Juno Therapeutics Inc. Recent Development
11.12 Medlmmune Inc.
11.12.1 Medlmmune Inc. Company Detail
11.12.2 Medlmmune Inc. Business Overview
11.12.3 Medlmmune Inc. Cell therapy Processing Introduction
11.12.4 Medlmmune Inc. Revenue in Cell therapy Processing Business (2019-2024)
11.12.5 Medlmmune Inc. Recent Development
11.13 NeoStem Oncology
11.13.1 NeoStem Oncology Company Detail
11.13.2 NeoStem Oncology Business Overview
11.13.3 NeoStem Oncology Cell therapy Processing Introduction
11.13.4 NeoStem Oncology Revenue in Cell therapy Processing Business (2019-2024)
11.13.5 NeoStem Oncology Recent Development
11.14 Neurotech USA
11.14.1 Neurotech USA Company Detail
11.14.2 Neurotech USA Business Overview
11.14.3 Neurotech USA Cell therapy Processing Introduction
11.14.4 Neurotech USA Revenue in Cell therapy Processing Business (2019-2024)
11.14.5 Neurotech USA Recent Development
11.15 Novartis
11.15.1 Novartis Company Detail
11.15.2 Novartis Business Overview
11.15.3 Novartis Cell therapy Processing Introduction
11.15.4 Novartis Revenue in Cell therapy Processing Business (2019-2024)
11.15.5 Novartis Recent Development
11.16 Persimmune Inc.
11.16.1 Persimmune Inc. Company Detail
11.16.2 Persimmune Inc. Business Overview
11.16.3 Persimmune Inc. Cell therapy Processing Introduction
11.16.4 Persimmune Inc. Revenue in Cell therapy Processing Business (2019-2024)
11.16.5 Persimmune Inc. Recent Development
11.17 Pluristem Therapeutics
11.17.1 Pluristem Therapeutics Company Detail
11.17.2 Pluristem Therapeutics Business Overview
11.17.3 Pluristem Therapeutics Cell therapy Processing Introduction
11.17.4 Pluristem Therapeutics Revenue in Cell therapy Processing Business (2019-2024)
11.17.5 Pluristem Therapeutics Recent Development
11.18 BioMed Valley Discoveries Inc.
11.18.1 BioMed Valley Discoveries Inc. Company Detail
11.18.2 BioMed Valley Discoveries Inc. Business Overview
11.18.3 BioMed Valley Discoveries Inc. Cell therapy Processing Introduction
11.18.4 BioMed Valley Discoveries Inc. Revenue in Cell therapy Processing Business (2019-2024)
11.18.5 BioMed Valley Discoveries Inc. Recent Development
11.19 Regeneron Pharmaceuticals Inc.
11.19.1 Regeneron Pharmaceuticals Inc. Company Detail
11.19.2 Regeneron Pharmaceuticals Inc. Business Overview
11.19.3 Regeneron Pharmaceuticals Inc. Cell therapy Processing Introduction
11.19.4 Regeneron Pharmaceuticals Inc. Revenue in Cell therapy Processing Business (2019-2024)
11.19.5 Regeneron Pharmaceuticals Inc. Recent Development
11.20 UCL Business PLC.
11.20.1 UCL Business PLC. Company Detail
11.20.2 UCL Business PLC. Business Overview
11.20.3 UCL Business PLC. Cell therapy Processing Introduction
11.20.4 UCL Business PLC. Revenue in Cell therapy Processing Business (2019-2024)
11.20.5 UCL Business PLC. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Anthrogenesis Corp.
BioNTech
Cell Ideas
Epic Sciences
Roche
FuGENE
IBC Pharmaceuticals Inc.
Bluebird Bio Inc.
Immodulon-Therapeutics
Immunomedics Inc.
Juno Therapeutics Inc.
Medlmmune Inc.
NeoStem Oncology
Neurotech USA
Novartis
Persimmune Inc.
Pluristem Therapeutics
BioMed Valley Discoveries Inc.
Regeneron Pharmaceuticals Inc.
UCL Business PLC.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂